Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Time course of the blood pressure lowering effect of liraglutide therapy in type 2 diabetes
2011-005344-95Phase 3Completed
- Sponsor
- Steno Diabetes Center
- Start
- Jun 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, single-arm trial of liraglutide in type 2 diabetes mellitus (T2DM) and hypertension (HTN), sponsored by Steno Diabetes Center. Primary endpoint: Ambulatory blood pressure. Started Jun 2012; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)
Beyond the preview
Go deeper on 2011-005344-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005344-95.